Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$555M |
| 2 |
Citigroup
C
|
+$407M |
| 3 |
Medtronic
MDT
|
+$401M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$392M |
| 5 |
Gilead Sciences
GILD
|
+$362M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.43B |
| 2 |
Amazon
AMZN
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$1.1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 5 |
Bank of America
BAC
|
+$726M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.02% |
| 2 | Healthcare | 2.92% |
| 3 | Consumer Discretionary | 2.17% |
| 4 | Financials | 2.1% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
13451
PUT
Full House Resorts
FLL
$81.7M
| $5.02K | ﹤0.01% |
1,000
+400
| +67% | +$2.04K |
|
13452
Paramount Gold Nevada
PZG
$132M
| $4.97K | ﹤0.01% |
12,313
-66,739
| -84% | -$29.1K |
|
|
GAU
13453
CALL
Galiano Gold
GAU
$547M
| $4.97K | ﹤0.01% |
3,500
+2,400
| +218% | +$3.83K |
|
|
BIOR
13454
CALL
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
| $4.97K | ﹤0.01% |
990
-230
| -19% | -$1.49K |
|
|
SBFMW
13455
Sunshine Biopharma Inc Warrant
SBFMW
$131K
| $4.96K | ﹤0.01% |
45,131
-23,239
| -34% | -$2.37K |
|
13456
PUT
Westamerica Bancorp
WABC
$1.38B
| $4.94K | ﹤0.01% |
100
-800
| -89% | -$40.7K |
|
13457
CALL
Anika Therapeutics
ANIK
$288M
| $4.94K | ﹤0.01% |
200
-2,500
| -93% | -$64.8K |
|
13458
CALL
Entera Bio
ENTX
$142M
| $4.94K | ﹤0.01% |
+2,600
| New | +$4.61K |
|
13459
PUT
Acco Brands
ACCO
$401M
| $4.92K | ﹤0.01% |
900
-1,000
| -53% | -$5.05K |
|
|
THTX
13460
PUT
DELISTED
Theratechnologies
THTX
| $4.92K | ﹤0.01% |
+4,000
| New | +$5.42K |
|
13461
Direxion Daily MSFT Bull 2X ETF
MSFU
$770M
| $4.9K | ﹤0.01% |
111
-21,909
| -99% | -$979K |
|
|
EVA
13462
PUT
DELISTED
Enviva Inc.
EVA
| $4.9K | ﹤0.01% |
12,100
-36,500
| -75% | -$15.9K |
|
13463
Able View Global Warrant
ABLVW
$120K
| $4.88K | ﹤0.01% |
240,139
+99,452
| +71% | +$2.98K |
|
13464
West Fraser Timber
WFG
$5.54B
| $4.87K | ﹤0.01% |
50
-10,957
| -100% | -$939K |
|
13465
PUT
Ennis
EBF
$559M
| $4.86K | ﹤0.01% |
+200
| New | +$4.62K |
|
|
RAPT
13466
PUT
DELISTED
RAPT Therapeutics
RAPT
| $4.82K | ﹤0.01% |
300
-5,563
| -95% | -$113K |
|
13467
PUT
Quest Resource Holding
QRHC
$33.7M
| $4.79K | ﹤0.01% |
600
+500
| +500% | +$4.27K |
|
13468
PUT
Rani Therapeutics
RANI
$89.5M
| $4.75K | ﹤0.01% |
2,200
-900
| -29% | -$2.58K |
|
13469
CALL
Schwab US Aggregate Bond ETF
SCHZ
$10.5B
| $4.75K | ﹤0.01% |
200
| – | – |
|
13470
Beneficient Warrant
BENFW
$154K
| $4.74K | ﹤0.01% |
657,727
-651,557
| -50% | -$6.19K |
|
|
ACR
13471
PUT
ACRES Commercial Realty
ACR
$102M
| $4.7K | ﹤0.01% |
300
-1,700
| -85% | -$25.4K |
|
13472
PUT
iShares US Treasury Bond ETF
GOVT
$43.7B
| $4.69K | ﹤0.01% |
200
-8,900
| -98% | -$206K |
|
13473
CALL
Orthofix Medical
OFIX
$421M
| $4.69K | ﹤0.01% |
300
-300
| -50% | -$4.81K |
|
13474
CALL
Aware
AWRE
$26.4M
| $4.67K | ﹤0.01% |
2,500
+1,300
| +108% | +$2.73K |
|
13475
PUT
Horizon Bancorp
HBNC
$1.06B
| $4.67K | ﹤0.01% |
300
+200
| +200% | +$2.98K |
|
Similar funds
Ken Griffin's Q3 2024 Portfolio in Review
As of Q3 2024, Ken Griffin held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Ken Griffin's Q3 2024 filing shows 1,614 new, 6,434 increased, 5,866 reduced and 1,611 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Ken Griffin's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
- Ken Griffin added most to NVIDIA in Q3 2024, an estimated $555M increase.
- Ken Griffin's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
- Ken Griffin fully exited Domino's in Q3 2024, selling an estimated $186M.
- Ken Griffin's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
- Ken Griffin opened 1,614 new positions and closed 1,611 in Q3 2024.
- Ken Griffin's portfolio value rose 4.9% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.